MTFMT
protein-codingmitochondrial methionyl-tRNA formyltransferase
Gene summary
The protein encoded by this nuclear gene localizes to the mitochondrion, where it catalyzes the formylation of methionyl-tRNA. [provided by RefSeq, Jun 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013987
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013987
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between MTFMT and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of February 26, 2020. The MTFMT gene encodes mitochondrial methionyl-tRNA formyltransferase which catalyzes the formylation of the mitochondrial methionine tRNA (Met-tRNAMet). This formylation is required for the initiation of translation and elongation of mitochondrial protein synthesis. The MTFMT gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2011 (PMID: 21907147). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six variants identified in ten cases in four publications (PMIDs: 21907147, 23499752, 30911575, 24461907). Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by biochemical function, functional alteration in non-patient cells, and rescue in patient cells (PMIDs: 29980628, 30087118, 21907147). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed from the first proposal of the association. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on February 26, 2020 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0013987
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013987
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Neurologic; Ophthalmologic
Intervention: Cardiovascular
Rationale: Among other multi-systemic manifestations, the condition may include cardiac manifestations such as Wolff-Parkinson-White syndrome, and surveillance may allow early diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MTFMT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_139242.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 47 | 2 | 50 | ||
| missense | 2 | 5 | 118 | 15 | 4 | 144 |
| nonsense | 11 | 4 | 2 | 17 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 6 | 4 | 2 | 12 | ||
| splice donor/acceptor (+/-2bp) | 4 | 5 | 9 | |||
| Total | 20 | 19 | 128 | 62 | 6 | 235 |
Highest pathogenic variant AF is 0.0006967377
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_640335.2 | 9 | MANE Select | |
| Ensembl | ENSP00000220058.4 | 9 | MANE Select | |
| Ensembl | ENSP00000443754.1 | 3 | Standard | |
| Ensembl | ENSP00000452646.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- One carbon pool by folate - Homo sapiens (human)
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- S-Adenosylhomocysteine (SAH) Hydrolase Deficiency
- Methionine Metabolism
- Folate malabsorption, hereditary
Biological Process
- translational initiation
- conversion of methionyl-tRNA to N-formyl-methionyl-tRNA
Molecular Function
- methionyl-tRNA formyltransferase activity
Cellular Component
- mitochondrion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000220058
- Coding exons
- 9
- Length
- 27133
- Individuals with no LoFs
- 124614
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 47
- Defined
- 124661
- p
- 0.000189
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.462 | 214 | 196 | 1.09 | 0.00000987 | 2467 |
| Missense (PolyPhen) | 70 | 69.718 | 1.004 | 810 | ||
| Synonymous | -0.381 | 76 | 71.9 | 1.06 | 0.00000399 | 768 |
| Loss of Function | 1.53 | 14 | 21.7 | 0.645 | 0.00000107 | 252 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00019 | 0.00019 | rare |
| European (Non-Finnish) | 0.00031 | 0.00031 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Formylates methionyl-tRNA in mitochondria. A single tRNA(Met) gene gives rise to both an initiator and an elongator species via an unknown mechanism (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 15 (COXPD15) [MIM:614947]: An autosomal recessive, mitochondrial, neurologic disorder characterized by features of Leigh syndrome and combined oxidative phosphorylation deficiency. Clinical features include mild global developmental delay, white matter abnormalities, ataxia, incoordination, speech and reading difficulties, T2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem. {ECO:0000269|PubMed:21907147}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:22499348}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.817
- RVIS EVS
- 0.71
- RVIS percentile EVS
- 85.53
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.960
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |